Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-22-020619
Filing Date
2022-08-05
Accepted
2022-08-05 19:22:05
Documents
1
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 5293
  Complete submission text file 0001127602-22-020619.txt   6711
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Telman Deborah H (Reporting) CIK: 0001860008 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19731 | Film No.: 221142089